“I think there's a couple of ways to think through that as I mentioned in the earlier comment, I mean, we are seeing an increase in demand. And that is -- we've been able to solve that fairly efficiently with just annual capital generation. And that -- but we do think that it is going to grow and we are constantly considering different ways to take advantage of that.”

In context

“elpful to have a wide breadth of product and expertise to work through the opportunities that are in the space and that's scale. That scale is a big benefit. So we're excited for the opportunities that are out there. And having done that we've been maintaining an up in quality mentality when it comes to investments. And with these rates it's worked pretty well. Alex Scott: Thank you. Operator: Our next question is from John Barnidge from Piper Sandler. Please go ahead. John Barnidge : Good morning. Thank you. Question about the value of new business slide that's updated not around IRRs, but can you talk about how higher rates in your outlook for that volume to possibly increase along with the value of new business? Thank you. John McCallion : Hey, John, it's John. Thanks for the question. I think there's a couple of ways to think through that as I mentioned in the earlier comment, I mean, we are seeing an increase in demand. And that is -- we've been able to solve that fairly efficiently with just annual capital generation. And that -- but we do think that it is going to grow and we are constantly considering different ways to take advantage of that. I think eventually as -- and maybe a little bit to an earlier question as volume and demand grows that could improve pricing to some degree. Right now I think it's fairly consistent and adjust with interest rates. But there is dynamics between volume and how that can also improve value but that will take some time. John Barnidge : Thank you very much. And my follow-up question. I know we're in the thick of renewal season for group benefits, but some retailers have started to comment about the impact from GLP or obesity treatment. How do you -- is that something that's come up within the renewal conversation at all? Just wanted to ask that. Thank you. Ramy Tadros : Yes. We're not really -- it's Ramy, here John. We're not really seeing any of those having any kind of material effect on our”